CAVERJECT vs LUMIGAN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. CAVERJECT and LUMIGAN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVERJECT	LUMIGAN
Rating	64/100	70/100
Pharmacy pays	—	$7.87 /mL
Type	RX	RX
Active ingredient	ALPROSTADIL	BIMATOPROST
Manufacturer	Pfizer	Abbvie
Dosage forms	Injectable	Drops
Drug class	Prostaglandin Analog	Prostaglandin Analog
Boxed warning	None	None
Treats	Aortic Arch Syndromes, Aortic Coarctation, Patent Ductus Arteriosus	Open-Angle Glaucoma

caverject lumigan

Rating

64/100

70/100

Pharmacy pays

—

$7.87 /mL

Type

Active ingredient

ALPROSTADIL

BIMATOPROST

Manufacturer

Pfizer

Abbvie

Dosage forms

Injectable

Drops

Drug class

Prostaglandin Analog

Boxed warning

None

Treats

Aortic Arch Syndromes, Aortic Coarctation, Patent Ductus Arteriosus

Open-Angle Glaucoma

Frequently asked questions

Which is better-rated, Caverject or Lumigan?

By our independent rating, Lumigan scores higher — 3.5 vs 3.2 out of 5 for Caverject. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Caverject and Lumigan?

Caverject contains Alprostadil, while Lumigan contains Bimatoprost — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.